Topics

RPS Diagnostics, Inc. (RPS) Company Profile

13:33 EDT 21st September 2019 | BioPortfolio

RPS Diagnostics (RPS) is an emerging developer, manufacturer, and marketer of cost-effective point-of-care (POC) tests for systemic infectious disease and antibiotic stewardship. The company’s innovative and patented FebriDx® test is a rapid, disposable, in-office test that uses a fingerstick blood sample to help identify a clinically significant immune response and differentiate bacterial from viral causes for fever in acute respiratory infection. With a 97% negative predictive value, FebriDx delivers results in 10 minutes and can be used to help triage infectious patients during the initial office visit, providing clinicians with actionable information that can be used to limit unnecessary antibiotics. At this time, the FebriDx test has not received U.S. Food and Drug Administration (FDA) clearance and is not commercially available in the United States. For more information on RPS and its products, visit RPSdetectors.com.


News Articles [439 Associated News Articles listed on BioPortfolio]

Lumos Diagnostics merges with RPS Diagnostics

Lumos Diagnostics is a California-based full-service point-of-care (POC) diagnostic development company, while RPS Diagnostics is a Florida-based commercial diagnostic developer, manufacturer, and mar...

Molecular Diagnostics Picks Up the Pace

Kalorama Information estimates that the market for molecular diagnostics is worth $8.7 billion and will reach $12.9 billion by 2024, outpacing growth in traditional in vitro diagnostics. The post Mole...

Co-Diagnostics opens new manufacturing joint venture facility in India

The manufacturing facility has been built for CoSara Diagnostics (CoSara), which marks one of the first facilities for manufacturing molecular diagnostics in India. Co-Diagnostics said that the facili...

The World Molecular Diagnostics Market, 2019 Edition – Focus on CT/NG, HPV, Hepatitis, HIV, HAIs, Respiratory Diseases, and Tuberculosis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The World Molecular Diagnostics Market, 8th Edition” report has been added to ResearchAndMarkets.com’s offering. Molecular diagnostics is a fa...

VC firm brings in $12.5M for Specific Diagnostics

Venture capital firm Telegraph Hill Partners has provided $12.5 million for in vitro diagnostics firm Specific Diagnostics.  -More- 

Burning Rock of Guangzhou Raises $126 Million for NGS Diagnostics

Burning Rock Biotech, a Guangzhou diagnostics company, closed a $126 million Series C financing led by GIC (the Sovereign Wealth Fund of Singapore). Burning Rock specializes in oncology diagnostics fo...

Genecast (Beijing) and US-based Interpace Form Diagnostics Partnership

Genecast (Beijing) Biotech, a cancer diagnostics company, partnered with Interpace Diagnostics of New Jersey to offer translational studies and clinical trial diagnostics to biopharma companies. Accor...

Exact Sciences and Genomic Health Merge to Form Leading Cancer Diagnostics Company

The combined companies will have revenue drivers of two commercially available diagnostics tools, Cologuard and Oncotype DX.

PubMed Articles [225 Associated PubMed Articles listed on BioPortfolio]

Introduction to Special Issue on "Electromagnetic Technologies for Medical Diagnostics: Fundamental Issues, Clinical Applications and Perspectives".

The application of microwave technologies in medical imaging and diagnostics is an emerging topic within the electromagnetic (EM) engineering community [...].

Possibilities of modern x-ray examination methods for diagnostics of hidden dental caries of approximal localization.

Introduction: In case of hidden carious cavities development on the approximal teeth surfaces, the clinical diagnostics of this process is difficult. Then, the diagnostics of carious lesion is not pos...

Optimization of the preanalytical phase of laboratory diagnostics in intensive care and disaster medicine.

The use of point-of-care diagnostics can prevent a number of complications and leading to improved health outcomes for patients in critical condition. Research have shown that elongation of the preana...

Nucleic acid diagnostics on the total integrated lab-on-a-disc for point-of-care testing.

Since the emergence of the lab-on-a-chip technology in 1979, a variety of microfluidic devices have been developed and utilized for chemical and biological applications. Among the microfluidic devices...

The labyrinth of product development and regulatory approvals in liquid biopsy diagnostics.

The evolution of chemistries and instrument platforms for Next Generation Sequencing (NGS) has led to sequencing of genomic variants in both tumor biopsies as well as in Circulating Tumor Cells (CTC) ...

Clinical Trials [281 Associated Clinical Trials listed on BioPortfolio]

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

Non-Invasive Diagnostics of Small Renal Masses

NiSAR is a Ph.D. study and consists of three substudies. Renal cancer is one of the most deadly urologic malignancies and accounts for 900 new cases and 300 deaths per year. An increase in...

Companies [972 Associated Companies listed on BioPortfolio]

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac ...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology inves...

Critical Diagnostics Critical Diagnostics

Critical Diagnostics (www.criticaldiagnostics.com) develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs...

ERBA Diagnostics Inc.

ERBA Diagnostics, Inc. (www.erbadiagnostics.com), headquartered in Miami Lakes, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distrib...

More Information about "RPS Diagnostics, Inc. (RPS)" on BioPortfolio

We have published hundreds of RPS Diagnostics, Inc. (RPS) news stories on BioPortfolio along with dozens of RPS Diagnostics, Inc. (RPS) Clinical Trials and PubMed Articles about RPS Diagnostics, Inc. (RPS) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of RPS Diagnostics, Inc. (RPS) Companies in our database. You can also find out about relevant RPS Diagnostics, Inc. (RPS) Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record